Phase I study and pharmacokinetics of CPT-11 with 5-day continuous infusion

Journal of the National Cancer Institute

Volumn 84, Issue 12, 1992, Pages 972-974

  Ohe, Yuichiro ^a   Sasaki, Yasutsuna ^a   Shinkai, Tetsu ^a   Eguchi, Kenji ^a   Tamura, Tomohide ^a   Kojima, Akira ^a   Kunikane, Hiroshi ^a   Okamoto, Hiroaki ^a   Karato, Atsuya ^a   Ohmatsu, Hironobu ^a   Kanzawa, Fumihiko ^b   Saijo, Nagahiro ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; IRINOTECAN;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; COLON CANCER; DIARRHEA; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; ESOPHAGUS CANCER; FEMALE; HUMAN; LEUKOPENIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHARYNX CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARCINOMA, NON-SMALL-CELL LUNG; COLONIC NEOPLASMS; DIARRHEA; DRUG EVALUATION; ESOPHAGEAL NEOPLASMS; HUMAN; LEUKOPENIA; LUNG NEOPLASMS; MIDDLE AGE; PHARYNGEAL NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0026631164     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/84.12.972     Document Type: Article

References (21)

1. WALL ME, WANI MC, COOK CE, et al: Plant antitumor agents. 1. The isolation and structure of camptothecin, a novel alkaloid leukemia and tumor inhibition from Camptolheca acuminata. J Am Chem Soc 88:3888-3890, 1966
2. THOMSEN B, MOLLERUP S, BONVEN BJ, et al: Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin. EMBO J 6:1817-1823, 1987
3. MATSUZAKI T, YOKOKURA T, MUTAI M, et al: Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice. Cancer Chemother Pharmacol 21:308-312, 1988
4. KANEDA N, NAGATA H, FURUTA T, et al: Metabolism and pharmacokinetics of the camptothecin analogue CPT-1 1 in the mouse [published erratum appears in Cancer Res 50:4451, 1990] Cancer Res 50:1715- 1720,1990
5. KANEDA N, YOKOKURA T: Nonlinear pharmacokinetics of CPT-11 in rats. Cancer Res 50:1721-1725, 1990
6. KUNIMOTO T, NITTA K, TAMAKA T, et al: Antitumor activity of 7-ethyl-10-[4-(lpiperidino)- 1 -piperidino] carbonyloxycamptothecin, a novel water-soluble derivative of camptothecin, against murine rumors. Cancer Res 47:5944-5947, 1987
7. TSURUO T, MATSUZAKI T, MATSUSHITA M, et al: Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo. Cancer Chemother Pharmacol 21:71- 74, 1988
8. FURUTA T, YOKOKURA T, MUTAI M, et al: Antitumor activity of CPT-11 against rat Walker 256 carcinoma. Jpn J Cancer Chemother 15:2757-2760, 1988
9. ANDOH T, ISHII K, SUZUKI Y, et al: Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc Natl Acad Sci USA 84:5565-5569, 1987
10. KANZAWA F, SUGIMOTO Y, MINATO K, et al: Establishment of a camptothecin analogue (CPT-I l)-resistant cell line of human non-small cell lung cancer Characterization and mechanism of resistance. Cancer Res 50.5919-5924, 1990
11. KAWATO Y, FURUTA T, AONUMA M, et al: Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice. Cancer Chemother Pharmacol 28:192-198, 1991
12. FUKUOKA M, NIITANI H, SUZUKI A, et al: A phase II study of CPT-I 1, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J Clin Oncol 10:16-20, 1992
13. NEGORO S, FUKUOKA M, NIFTANI H, et al: Phase II study of CPT-I 1, new camptothecin derivative, in small-cell lung cancer (SCLC). Proc ASCO 10:241, 1991
14. OHNO R, OKADA K, MASAOKA T, et al: An early phase II study of CPT-1 1: A new derivative of camptothecin, for the treatment of leukemia and lymphoma J Clin Oncol 8:1907-1912, 1990
15. TAKEUCHI S, TAKAMIZAWA H, TAKEDA Y, et al: Clinical study of CPT-11, camptothecin derivative, on gynecological malignancy, Proc ASCO 10:189, 1991
16. SHIMADA Y, YOSHIDA M, WAKUI A. et al: Phase II study of CPT-1 I, new camptothecin derivative, in the patients with metastatic colorectal cancer. Proc ASCO 10:135, 1991
17. TAKEUCHI S, TAKAMIZAWA H, TAKEDA Y. et al: An early phase II study of CPT-11 for gynecologic cancer. Jpn J Cancer Chemother 18:579-584, 1991
18. MILLER AB, HOOGSTRATEN B, STAQUET M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
19. NEGORO S, FUKUOKA M, MASUDA N, et al: Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced nonsmall- cell lung cancer. J Natl Cancer Inst 83:1164-1168, 1991
20. TAGUCHI T, WAKUI A, HASEGAWA K. et al: Phase I clinical study of CPT-11. Jpn J Cancer Chemother 17:115-120, 1990
21. TSUJI T. KANEDA N, KADO K, et al: CPT-11 converting enzyme from rat serum: Purification and some properties. J Pharmacobiodyn 14:341-349, 1991